204 related articles for article (PubMed ID: 32250526)
1. Emerging opportunities to harness real world data: An introduction to data sources, concepts, and applications.
O'Leary CP; Cavender MA
Diabetes Obes Metab; 2020 Apr; 22 Suppl 3():3-12. PubMed ID: 32250526
[TBL] [Abstract][Full Text] [Related]
2. Understanding the challenge of comparative effectiveness research in focal epilepsy: A review of network meta-analyses and real-world evidence on antiepileptic drugs.
Thieffry S; Klein P; Baulac M; Plumb J; Pelgrims B; Steeves S; Borghs S
Epilepsia; 2020 Apr; 61(4):595-609. PubMed ID: 32201951
[TBL] [Abstract][Full Text] [Related]
3. Generate Analysis-Ready Data for Real-world Evidence: Tutorial for Harnessing Electronic Health Records With Advanced Informatic Technologies.
Hou J; Zhao R; Gronsbell J; Lin Y; Bonzel CL; Zeng Q; Zhang S; Beaulieu-Jones BK; Weber GM; Jemielita T; Wan SS; Hong C; Cai T; Wen J; Ayakulangara Panickan V; Liaw KL; Liao K; Cai T
J Med Internet Res; 2023 May; 25():e45662. PubMed ID: 37227772
[TBL] [Abstract][Full Text] [Related]
4. The Case for Real-world Evidence in the Future of Clinical Research on Chronic Myeloid Leukemia.
Webster J; Smith BD
Clin Ther; 2019 Feb; 41(2):336-349. PubMed ID: 30709609
[TBL] [Abstract][Full Text] [Related]
5. Meta-analyses using real-world data to generate clinical and epidemiological evidence: a systematic literature review of existing recommendations.
Briere JB; Bowrin K; Taieb V; Millier A; Toumi M; Coleman C
Curr Med Res Opin; 2018 Dec; 34(12):2125-2130. PubMed ID: 30217138
[TBL] [Abstract][Full Text] [Related]
6. Translational hurdles with cannabis medicines.
Graham M; Lucas CJ; Schneider J; Martin JH; Hall W
Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1325-1330. PubMed ID: 32281186
[TBL] [Abstract][Full Text] [Related]
7. Creating and using real-world evidence to answer questions about clinical effectiveness.
de Lusignan S; Crawford L; Munro N
J Innov Health Inform; 2015 Nov; 22(3):368-73. PubMed ID: 26577427
[TBL] [Abstract][Full Text] [Related]
8. Real-World Evidence: A Primer.
Dang A
Pharmaceut Med; 2023 Jan; 37(1):25-36. PubMed ID: 36604368
[TBL] [Abstract][Full Text] [Related]
9. Strengths and weaknesses of 'real-world' studies involving non-vitamin K antagonist oral anticoagulants.
Camm AJ; Fox KAA
Open Heart; 2018; 5(1):e000788. PubMed ID: 29713485
[TBL] [Abstract][Full Text] [Related]
10. [Real-world evidence : Benefits and limitations in multiple sclerosis research].
Ziemssen T; Rothenbacher D; Kuhle J; Berger T
Nervenarzt; 2017 Oct; 88(10):1153-1158. PubMed ID: 28776214
[TBL] [Abstract][Full Text] [Related]
11. Use of real-world evidence for oncology clinical decision making in emerging economies.
Petracci F; Ghai C; Pangilinan A; Suarez LA; Uehara R; Ghosn M
Future Oncol; 2021 Aug; 17(22):2951-2960. PubMed ID: 34044583
[TBL] [Abstract][Full Text] [Related]
12. Replication of Randomized, Controlled Trials Using Real-World Data: What Could Go Wrong?
Thompson D
Value Health; 2021 Jan; 24(1):112-115. PubMed ID: 33431143
[TBL] [Abstract][Full Text] [Related]
13. Trial designs using real-world data: The changing landscape of the regulatory approval process.
Baumfeld Andre E; Reynolds R; Caubel P; Azoulay L; Dreyer NA
Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1201-1212. PubMed ID: 31823482
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analyses using real-world data: an overview of the literature.
Bowrin K; Briere JB; Levy P; Millier A; Clay E; Toumi M
J Med Econ; 2019 Jun; 22(6):545-553. PubMed ID: 30816067
[No Abstract] [Full Text] [Related]
15. Real-World Data: Applications and Relevance to Cancer Clinical Trials.
Gross AJ; Pisano CE; Khunsriraksakul C; Spratt DE; Park HS; Sun Y; Wang M; Zaorsky NG
Semin Radiat Oncol; 2023 Oct; 33(4):374-385. PubMed ID: 37684067
[TBL] [Abstract][Full Text] [Related]
16. Real-world evidence in rheumatic diseases: relevance and lessons learnt.
Misra DP; Agarwal V
Rheumatol Int; 2019 Mar; 39(3):403-416. PubMed ID: 30725156
[TBL] [Abstract][Full Text] [Related]
17. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
[TBL] [Abstract][Full Text] [Related]
18. Real world evidence: An Indian perspective.
Dang A; Vallish BN
Perspect Clin Res; 2016; 7(4):156-160. PubMed ID: 27843789
[TBL] [Abstract][Full Text] [Related]
19. Real-world evidence and product development: Opportunities, challenges and risk mitigation.
Naidoo P; Bouharati C; Rambiritch V; Jose N; Karamchand S; Chilton R; Leisegang R
Wien Klin Wochenschr; 2021 Aug; 133(15-16):840-846. PubMed ID: 33837463
[TBL] [Abstract][Full Text] [Related]
20. Replication of randomized clinical trial results using real-world data: paving the way for effectiveness decisions.
Sheffield KM; Dreyer NA; Murray JF; Faries DE; Klopchin MN
J Comp Eff Res; 2020 Oct; 9(15):1043-1050. PubMed ID: 32914653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]